GO:0006865 amino acid transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006865 amino acid transport describes the directed movement of amino acids into, out of, or within cells via transporters or pores.
• Amino acid transport is essential for nutrient uptake, cellular metabolism, and nitrogen balance across all domains of life.
• Dozens of transporter families (SLC, CAT, LAT, etc.) mediate amino acid transport with varying substrate specificity and coupling mechanisms.
• Defects in amino acid transport cause inherited metabolic disorders such as cystinuria, Hartnup disease, and lysinuric protein intolerance.
• Amino acid transporters are regulated by nutrient availability, hormones, and stress signals, including the mTOR pathway and amino acid sensing.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of transporter function in health and disease.
Description
Amino acid transport (GO:0006865) is the directed movement of amino acids, organic acids containing one or more amino substituents, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is fundamental to life, supplying cells with building blocks for protein synthesis, energy metabolism, and signaling molecules. In organisms ranging from bacteria to humans, amino acid transporters are embedded in membranes and couple substrate movement to ion gradients or ATP hydrolysis. The physiological importance of amino acid transport is underscored by its role in intestinal absorption, renal reabsorption, placental nutrient transfer, and neurotransmitter recycling. Defects in specific transporters lead to inherited metabolic diseases, and altered transport activity contributes to cancer, neurodegeneration, and immune dysfunction. Researchers study amino acid transport to understand nutrient sensing, metabolic regulation, and to develop therapeutic strategies targeting transporter proteins. The QuickGO definition provides a precise scope: the directed movement of amino acids across membranes or within cells, mediated by transporters or pores.
amino acid transport At A Glance
| GO ID | GO:0006865 |
|---|---|
| GO term | amino acid transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of amino acids across membranes or within cells via transporters or pores |
| Major transporter families | SLC superfamily (e.g., SLC1, SLC3, SLC7, SLC38), CAT transporters, bacterial ABC transporters |
| Cellular locations | Plasma membrane, mitochondrial membrane, lysosomal membrane, bacterial inner membrane |
| Physiological roles | Intestinal absorption, renal reabsorption, placental transfer, neurotransmitter recycling, nitrogen homeostasis |
| Disease relevance | Cystinuria, Hartnup disease, lysinuric protein intolerance, iminoglycinuria, cancer metabolism |
What Is GO:0006865?
GO:0006865 amino acid transport is defined as the directed movement of amino acids, organic acids containing one or more amino substituents, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This biological process encompasses all mechanisms that move amino acids across biological membranes, including facilitated diffusion, secondary active transport, and primary active transport. It does not include the synthesis or degradation of amino acids, but rather their translocation. The process is mediated by a diverse array of membrane proteins, including solute carrier (SLC) family members, ATP-binding cassette (ABC) transporters, and bacterial periplasmic binding proteins.
Why Is amino acid transport Important in Cell Biology?
Amino acid transport is a cornerstone of cellular and organismal physiology, controlling the availability of amino acids for protein synthesis, energy production, and signaling. In mammals, transport across epithelial barriers in the intestine and kidney determines systemic amino acid balance, and in the placenta it supports fetal growth. In the brain, transporters regulate neurotransmitter pools and protect against excitotoxicity. In bacteria, amino acid transport is critical for nutrient acquisition and survival in diverse environments. Dysregulated transport is linked to metabolic disorders, cancer, and neurological diseases, making transporters attractive drug targets. Understanding the molecular mechanisms and regulation of amino acid transport is therefore essential for both basic biology and translational research.
• Provides essential amino acids for protein synthesis and cell growth.
• Maintains nitrogen balance and acid-base homeostasis in the kidney.
• Enables intestinal absorption of dietary amino acids.
• Supports placental nutrient transfer for fetal development.
• Regulates neurotransmitter precursors and synaptic signaling in the brain.
• Mediates bacterial nutrient uptake and virulence.
• Mutations in transporters cause inherited metabolic disorders such as cystinuria and Hartnup disease.
• Altered transport activity contributes to cancer cell proliferation and survival.
• Serves as a target for pharmacological modulation in metabolic and neurological diseases.
• Provides a model system for studying membrane protein structure, function, and evolution.
What Happens During amino acid transport?
Substrate recognition and binding
In simple terms: The transporter first grabs the amino acid it will carry.
Amino acid transporters possess substrate-binding sites that recognize specific amino acids or classes of amino acids based on size, charge, and hydrophobicity. For example, cationic amino acid transporters (CATs) preferentially bind arginine, lysine, and ornithine, while L-type amino acid transporters (LATs) handle large neutral amino acids. Binding induces conformational changes that initiate the transport cycle. In bacteria, periplasmic binding proteins capture amino acids and deliver them to membrane-embedded transporters.
Translocation across the membrane
In simple terms: The transporter moves the amino acid through the membrane.
Following substrate binding, the transporter undergoes a series of conformational changes that expose the substrate to alternating sides of the membrane, a mechanism known as the alternating access model. Secondary transporters couple amino acid movement to the downhill flow of ions such as Na+ or H+, while primary active transporters use ATP hydrolysis to drive transport against a concentration gradient. The translocation step is highly regulated and can be rate-limiting under certain physiological conditions.
Substrate release and resetting
In simple terms: The amino acid is released inside the cell, and the transporter resets.
After translocation, the amino acid is released into the cytoplasm or into an intracellular compartment, and the transporter returns to its original conformation to begin a new cycle. The release step is often coupled to the binding of ions or other solutes, ensuring directional transport. In epithelial cells, this process is polarized: transporters on the apical membrane mediate uptake from the lumen, while basolateral transporters release amino acids into the blood.
Regulation of transport activity
In simple terms: Cells adjust how much amino acid they take up based on need.
Amino acid transport is dynamically regulated at multiple levels, including transporter gene expression, protein trafficking, and post-translational modifications. Nutrient availability, hormones such as insulin, and stress signals modulate transport activity. For instance, the CAT-1 transporter is regulated by amino acid availability and cellular stress through mechanisms involving mRNA translation and protein stability. In Saccharomyces cerevisiae, amino acid transporters are controlled by the SPS (Ssy1-Ptr3-Ssy5) sensing pathway and the TORC1 pathway in response to extracellular amino acids.
Key Genes Involved in GO:0006865 amino acid transport
The following genes encode representative amino acid transporters and related proteins that mediate or regulate amino acid transport across membranes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC7A1 (CAT-1) | Cationic amino acid transporter; mediates uptake of arginine, lysine, ornithine | Regulation by amino acid availability and stress; model for transporter biology |
| SLC7A2 (CAT-2) | Cationic amino acid transporter; inducible by cytokines | Inflammation and immune response; arginine metabolism |
| SLC3A2 (4F2hc) | Heavy chain subunit of heteromeric amino acid transporters | Chaperone-like function; mutations cause cystinuria-like phenotypes |
| SLC7A9 | Light chain of cystine/neutral amino acid transporter | Mutations cause cystinuria; renal reabsorption |
| SLC6A19 | Neutral amino acid transporter in kidney and intestine | Hartnup disease; mutations impair neutral amino acid transport |
| SLC7A7 | Lysinuric protein intolerance transporter | Mutations cause lysinuric protein intolerance; arginine/lysine transport |
| SLC38A1 | System A glutamine transporter | Cancer metabolism; glutamine uptake |
| SLC38A2 | System A amino acid transporter | Nutrient sensing; mTORC1 activation |
| SLC1A1 | Glutamate transporter | Neurotransmission; excitotoxicity |
| SLC1A2 | Glial glutamate transporter | Neurodegeneration; glutamate clearance |
| SLC6A1 | GABA transporter | Neurotransmission; epilepsy |
| SLC36A1 | Proton-coupled amino acid transporter | Lysosomal amino acid efflux; mTORC1 signaling |
| SLC15A4 | Peptide/histidine transporter | Immune regulation; endolysosomal transport |
| GAP1 | General amino acid permease in yeast | Nitrogen catabolite repression; model for transport regulation |
| TAT1 | Aromatic amino acid transporter | Thyroid hormone synthesis; transport of tyrosine |
| B0AT1 | Neutral amino acid transporter in intestine | Hartnup disease; amino acid absorption |
| LAT1 | L-type amino acid transporter | Cancer; leucine uptake and mTORC1 signaling |
| SNAT2 | Sodium-coupled neutral amino acid transporter | Cell growth; amino acid sensing |
How Is amino acid transport Regulated?
Amino acid transport is regulated at transcriptional, translational, and post-translational levels to match cellular demand and environmental availability. In yeast, the SPS sensor and TORC1 pathway control the expression of amino acid permeases in response to extracellular amino acids. In mammals, the mTORC1 pathway senses intracellular amino acid levels, particularly leucine and arginine, and regulates transporter expression and activity. The CAT-1 transporter is regulated by amino acid availability through a mechanism involving upstream open reading frames in its mRNA and by stress-induced phosphorylation of eIF2α. Hormones such as insulin and glucagon also modulate transport activity in tissues like muscle and liver. Additionally, transporter trafficking to and from the plasma membrane provides rapid control of transport capacity.
amino acid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A9 | Cystinuria | Knockout mouse; renal epithelial cell lines |
| SLC6A19 | Hartnup disease | Knockout mouse; intestinal organoids |
| SLC7A7 | Lysinuric protein intolerance | Patient-derived iPSCs; knock-in mouse |
| SLC7A5 (LAT1) | Cancer proliferation | Cancer cell line knockout; xenograft models |
| SLC1A2 | Neurodegeneration, epilepsy | Conditional knockout mouse; neuronal cultures |
Inherited metabolic disorders of amino acid transport
Mutations in amino acid transporters cause a spectrum of inherited metabolic disorders. Cystinuria results from defective transport of cystine and dibasic amino acids in the renal proximal tubule, leading to kidney stones. Hartnup disease is caused by mutations in SLC6A19, impairing neutral amino acid absorption in the intestine and kidney, and can present with pellagra-like symptoms. Lysinuric protein intolerance, due to SLC7A7 mutations, affects cationic amino acid transport and causes hyperammonemia and growth failure. These disorders highlight the critical role of specific transporters in human physiology.
Amino acid transport in cancer
Cancer cells often upregulate amino acid transporters to support rapid proliferation. For example, LAT1 (SLC7A5) is overexpressed in many cancers and correlates with poor prognosis, as it supplies leucine for mTORC1 activation. Glutamine transporters such as SLC38A1 and SLC1A5 are also frequently upregulated, supporting biosynthetic demands. Targeting these transporters is an active area of therapeutic development.
Neurological and neurodegenerative diseases
In the brain, amino acid transporters regulate neurotransmitter levels and protect against excitotoxicity. Dysfunction of glutamate transporters (e.g., SLC1A2) is implicated in amyotrophic lateral sclerosis and epilepsy. GABA transporters (e.g., SLC6A1) are targets for anticonvulsant drugs. Altered amino acid transport across the blood-brain barrier may contribute to neurodegeneration.
From amino acid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of transporter X impair amino acid uptake? | CRISPR knockout cell line (e.g., HEK293T, HeLa) |
| Does a specific point mutation affect substrate specificity? | Point-mutation knock-in via CRISPR |
| Can a tagged transporter be used for localization studies? | Knock-in of fluorescent or epitope tag |
| Does overexpression of transporter X drive proliferation? | Stable overexpression cell line |
| What is the role of transporter X in a whole organism? | Knockout mouse model |
| How does transporter X contribute to drug resistance? | CRISPR library screening in cancer cells |
How to Study the amino acid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity and kinetics | Characterizing transporter substrate specificity |
| Electrophysiology | Ion currents and stoichiometry | Mechanistic studies of electrogenic transporters |
| Proteomics | Protein interactions and modifications | Identifying transporter complexes |
| CRISPR knockout screen | Gene essentiality under selective conditions | Discovering nutrient transporters in cancer |
| RNA-seq | Transporter gene expression | Profiling transport regulation |
| Immunofluorescence | Subcellular localization | Determining membrane trafficking |
| Structural biology (cryo-EM) | 3D structure of transporters | Understanding transport mechanism |
Transport assays
Radiolabeled or fluorescent amino acid uptake assays are used to measure transport activity in cells or membrane vesicles. These assays can determine kinetic parameters (Km, Vmax) and substrate specificity. For example, uptake of 3H-arginine in Xenopus oocytes expressing CAT-1 is a classic method.
Electrophysiology
Two-electrode voltage clamp and patch-clamp recordings measure transporter-associated currents, revealing stoichiometry and voltage dependence. This is particularly useful for electrogenic transporters.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify transporter complexes and post-translational modifications. Proximity labeling (e.g., BioID) can map transporter interactomes.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify transporters required for cell growth under specific nutrient conditions. This approach has uncovered novel amino acid transporters in cancer metabolism.
How CRISPR Can Be Used to Study GO:0006865 amino acid transport
Knockout
CRISPR knockout of amino acid transporter genes (e.g., SLC7A5, SLC1A2) enables loss-of-function studies to determine their role in nutrient uptake, cell growth, and disease models. Knockout cell lines can be used for metabolic profiling and drug sensitivity assays.
Point Mutation
Introducing disease-associated point mutations (e.g., in SLC6A19 or SLC7A9) via CRISPR base editing or homology-directed repair allows functional characterization of transport defects and validation of pathogenic variants.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous transporter loci facilitates real-time imaging and biochemical purification of transporter complexes. This approach preserves native regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of transporters (e.g., LAT1) can model transporter upregulation in cancer and identify downstream metabolic rewiring.
How EDITGENE Supports amino acid transport Research
Researchers studying amino acid transport-related genes often need to determine whether a candidate transporter is causally involved in a specific physiological or pathological process. This requires precise genetic models that can isolate the contribution of individual transporters from the complex network of amino acid transport systems. EDITGENE provides a comprehensive suite of CRISPR-based services to generate such models efficiently and reliably.
Contact EDITGENE today to design your custom CRISPR model for amino acid transport research.
Frequently Asked Questions About amino acid transport
What is amino acid transport (GO:0006865)?
Amino acid transport is the directed movement of amino acids into, out of, or within a cell, or between cells, mediated by transporters or pores.
What genes are involved in amino acid transport?
Key genes include SLC7A1 (CAT-1), SLC7A5 (LAT1), SLC6A19, SLC7A9, SLC1A2, and many other SLC family members.
Why is amino acid transport important for health?
It supplies amino acids for protein synthesis, maintains nitrogen balance, supports neurotransmission, and its defects cause inherited metabolic disorders.
What diseases are linked to amino acid transport defects?
Cystinuria, Hartnup disease, lysinuric protein intolerance, and iminoglycinuria are caused by mutations in amino acid transporters.
How is amino acid transport regulated?
It is regulated by nutrient availability, hormones, and signaling pathways such as mTORC1 and the SPS sensor in yeast.
What methods are used to study amino acid transport?
Radiolabeled uptake assays, electrophysiology, proteomics, CRISPR screens, and structural biology are commonly used.
Can CRISPR be used to study amino acid transporters?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable precise functional studies of transporters.
What is the role of amino acid transport in cancer?
Cancer cells upregulate transporters like LAT1 to support proliferation and mTORC1 signaling.
How does amino acid transport work in the kidney?
Kidney transporters reabsorb amino acids from filtrate, and defects cause aminoaciduria.
What is the difference between amino acid transport and amino acid metabolism?
Transport moves amino acids across membranes, while metabolism involves their synthesis, degradation, and interconversion.
Conclusion
Amino acid transport (GO:0006865) is a fundamental biological process that underpins nutrient acquisition, cellular metabolism, and organismal physiology. The diversity of transporters and their regulation reflects the complexity of amino acid homeostasis, and their dysfunction is linked to a wide range of human diseases. Continued research using advanced genetic models and functional assays will further illuminate the mechanisms and therapeutic potential of amino acid transport systems.
References
- 1. Bianchi F et al.. 2019. Regulation of Amino Acid Transport in Saccharomyces cerevisiae.. Microbiol Mol Biol Rev 83(4) PMID: 31619504
- 2. Yahyaoui R et al.. 2019. Amino Acid Transport Defects in Human Inherited Metabolic Disorders.. Int J Mol Sci 21(1) PMID: 31878022
- 3. Moe AJ. 1995. Placental amino acid transport.. Am J Physiol 268(6 Pt 1):C1321-31 PMID: 7611349
- 4. Verrey F et al.. 2009. Kidney amino acid transport.. Pflugers Arch 458(1):53-60 PMID: 19184091
- 5. Bröer S. 2008. Amino acid transport across mammalian intestinal and renal epithelia.. Physiol Rev 88(1):249-86 PMID: 18195088
- 6. Haney SA et al.. 1992. Amino acid transport in bacteria.. Int Rev Cytol 137:37-95 PMID: 1428673
- 7. Schweikhard ES et al.. 2012. Amino acid secondary transporters: toward a common transport mechanism.. Curr Top Membr 70:1-28 PMID: 23177982
- 8. Hatzoglou M et al.. 2004. Regulation of cationic amino acid transport: the story of the CAT-1 transporter.. Annu Rev Nutr 24:377-99 PMID: 15459982
